This inventor holds 1 USPTO granted patent. Top assignee: Quanterix Corporation. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Jeremy Lambert: Innovator in Quantitative Antibody Testing
Introduction
Jeremy Lambert is an accomplished inventor based in Billerica, MA (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of antibody testing. His innovative work has the potential to enhance the detection of infectious diseases, including COVID-19.
Latest Patents
Jeremy Lambert holds a patent for a quantitative antibody test. This patent relates to methods and compositions, such as kits, for quantitatively detecting an antibody of a subject to an infectious organism. Specifically, it provides methods for detecting a human antibody to SARS-CoV-2 polypeptide or S (spike) polypeptide. The applications of this patent are crucial for improving diagnostic accuracy and patient care.
Career Highlights
Jeremy is currently employed at Quanterix Corporation, where he continues to develop innovative solutions in the field of diagnostics. His work at Quanterix Corporation has positioned him as a key player in advancing medical technology.
Collaborations
Some of his notable coworkers include Dawn Mattoon and Syrena Fernandes. Their collaborative efforts contribute to the ongoing success and innovation at Quanterix Corporation.
Conclusion
Jeremy Lambert's contributions to quantitative antibody testing exemplify the impact of innovation in medical diagnostics. His work not only advances scientific understanding but also enhances public health outcomes.